Alan F. List

机构：Precision BioSciences (United States), TE Laboratories (Ireland) · ORCID：0000-0002-1647-2972

发表论文 1029 篇 · 总被引 35877 次 · h-index 89

代表论文

• Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML (2025 · HemaSphere · 被引 15)
• Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement (2025 · Blood · 被引 11)
• Real‐world, multi‐omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS) (2026 · HemaSphere · 被引 1)
• Abstract 2127: Efficacy of monoclonal antibodies against pathogenic S100A8/9 in myelodysplasia and leukemia models (2025 · Cancer Research · 被引 1)
• Supplementary Figure 1 from HG-829 Is a Potent Noncompetitive Inhibitor of the ATP-Binding Cassette Multidrug Resistance Transporter <i>ABCB1</i> (2026)
• Supplementary Tables 1-2 from HG-829 Is a Potent Noncompetitive Inhibitor of the ATP-Binding Cassette Multidrug Resistance Transporter ABCB1 (2026)